Search

Caryl Ellen Sortwell

from Grand Rapids, MI
Age ~59

Caryl Sortwell Phones & Addresses

  • 553 Madison Ave, Grand Rapids, MI 49503 (616) 451-4336
  • 2142 Sinton Ave, Cincinnati, OH 45206 (513) 861-2492 (513) 861-2553
  • Troy, MI
  • 4326 Hamlin Ave, Chicago, IL 60618 (773) 583-2749
  • 2556 Kimball Ave, Chicago, IL 60647 (773) 252-2338
  • Saint Simons Island, GA
  • Wheaton, IL

Work

Company: University of cincinnati Position: Associate professor

Education

Degree: Doctorates, Doctor of Philosophy School / High School: University of Illinois at Chicago 1988 to 1994 Specialities: Biology, Anatomy, Philosophy

Languages

English

Interests

Home Improvement • Kids • Reading

Industries

Research

Resumes

Resumes

Caryl Sortwell Photo 1

Professor And Associate Chair

View page
Location:
553 Madison Ave southeast, Grand Rapids, MI 49503
Industry:
Research
Work:
University of Cincinnati
Associate Professor
Education:
University of Illinois at Chicago 1988 - 1994
Doctorates, Doctor of Philosophy, Biology, Anatomy, Philosophy
University of Illinois at Urbana - Champaign 1983 - 1987
Bachelors, Bachelor of Science, Psychology
Interests:
Home Improvement
Kids
Reading
Languages:
English

Publications

Us Patents

Erythropoietin Administration To Improve Graft Survival

View page
US Patent:
7459152, Dec 2, 2008
Filed:
Apr 23, 2004
Appl. No.:
10/830705
Inventors:
Caryl E. Sortwell - Chicago IL, US
Timothy J. Collier - Deerfield IL, US
Assignee:
Rush University Medical Center - Chicago IL
International Classification:
C12N 5/08
US Classification:
424 931, 424 937, 435377, 435365, 435368
Abstract:
The present invention provides methods, compounds and kits for increasing the viability of cells. The methods involve treating cells that make up a tissue graft with erythropoietin before, during or after delivery or administration. The method can employ cells of different types, including cells of neural or paraneural origin, such as adrenal chromaffin cells. Also useful are cell lines grown in vitro. Cells not of neural or paraneural origin, such as fibroblasts, may also be used following genetic alteration to express a desired neural product such as a neurotransmitter or a neuronal growth factor. The method is used to treat neurological diseases such as Parkinson's disease, Alzheimer's disease, Huntington's disease, epilepsy, and traumatic brain or spinal cord injury.

Allantoin Administration For The Treatment Of Neurodegenerative Disease And Neurotrauma

View page
US Patent:
20120128654, May 24, 2012
Filed:
Apr 23, 2010
Appl. No.:
13/265584
Inventors:
Brian T. Terpstra - Lowell IN, US
Caryl E. Sortwell - Grand Rapids MI, US
Assignee:
UNIVERSITY OF CINCINNATI - Cincinnati OH
International Classification:
A61K 31/4166
A61P 25/16
A61P 25/00
A61P 25/14
A61K 31/616
A61K 31/445
A61K 38/18
A61K 31/57
A61K 38/49
A61P 25/28
A61K 31/426
US Classification:
424 9464, 514390, 514367, 514319, 514 77, 514171, 514161
Abstract:
Methods for inhibiting the progression of neurodegenerative diseases and treating neurotrauma-induced damage and cerebrovascular disease are provided herein, the methods including the administration of a safe and effective amount of allantoin to a patient in need thereof. Also provided are pharmaceutical compositions including allantoin for the inhibition of the progression of neurodegenerative diseases and for the treatment of neurotrauma-induced damage and cerebrovascular disease.

Method For Alleviating Depression

View page
US Patent:
49801740, Dec 25, 1990
Filed:
Dec 23, 1988
Appl. No.:
7/289609
Inventors:
Jacqueline Sagen - Chicago IL
Caryl E. Sortwell - Chicago IL
George D. Pappas - Chicago IL
International Classification:
A61K 3530
A61K 3555
A61B 1700
US Classification:
424563
Abstract:
A novel method for alleviating depression comprises implanting monoamine producing living cells in the CNS of depressive subjects.

Nurr1 As A Genetic Target For Treating Levodopa-Induced Dyskinesias In Parkinson's Disease

View page
US Patent:
20170198295, Jul 13, 2017
Filed:
Jun 5, 2015
Appl. No.:
15/316726
Inventors:
- East Lansing MI, US
Jack W. Lipton - Grand Rapids MI, US
Nicholas Kanaan - Grand Rapids MI, US
Timothy Collier - Grand Rapids MI, US
Caryl E. Sortwell - Grand Rapids MI, US
International Classification:
C12N 15/113
C12N 7/00
Abstract:
Methods of treating movement disorders by reducing the activity of Nurr1 are disclosed. These methods are particularly applicable to subjects suffering from Parkinson's disease who have either developed levodopa-induced dyskinesia (LID) or are at risk of developing LID. In some aspects, the invention relates to a method for treating a movement disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a composition, wherein said composition reduces the activity of a nuclea receptor related 1 protein (“Nurr1”). In some embodiments, the movement disorder is a dyskinesia. The movement disorder may be a levodopa-induced dyskinesia.
Caryl Ellen Sortwell from Grand Rapids, MI, age ~59 Get Report